UA95921C2 - Композиции, которые включают слаборастворимые в воде фармацевтические вещества и противомикробные вещества - Google Patents
Композиции, которые включают слаборастворимые в воде фармацевтические вещества и противомикробные веществаInfo
- Publication number
- UA95921C2 UA95921C2 UAA200803884A UAA200803884A UA95921C2 UA 95921 C2 UA95921 C2 UA 95921C2 UA A200803884 A UAA200803884 A UA A200803884A UA A200803884 A UAA200803884 A UA A200803884A UA 95921 C2 UA95921 C2 UA 95921C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compositions
- water soluble
- poorly water
- soluble pharmaceutical
- agents
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 239000004599 antimicrobial Substances 0.000 title abstract 4
- 239000008177 pharmaceutical agent Substances 0.000 title abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 3
- 102000014914 Carrier Proteins Human genes 0.000 abstract 2
- 108010078791 Carrier Proteins Proteins 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 230000002110 toxicologic effect Effects 0.000 abstract 1
- 231100000759 toxicological effect Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A61K38/385—Serum albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71286505P | 2005-08-31 | 2005-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA95921C2 true UA95921C2 (ru) | 2011-09-26 |
Family
ID=41449779
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200803886A UA96273C2 (ru) | 2005-08-31 | 2006-08-30 | Композиция доцетаксела и цитрата для лечения рака |
| UAA200803884A UA95921C2 (ru) | 2005-08-31 | 2006-08-30 | Композиции, которые включают слаборастворимые в воде фармацевтические вещества и противомикробные вещества |
| UAA201109120A UA108840C2 (uk) | 2005-08-31 | 2006-08-30 | Композиція і спосіб одержання лікарського засобу на основі доцетакселу з підвищеною стабільністю |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200803886A UA96273C2 (ru) | 2005-08-31 | 2006-08-30 | Композиция доцетаксела и цитрата для лечения рака |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201109120A UA108840C2 (uk) | 2005-08-31 | 2006-08-30 | Композиція і спосіб одержання лікарського засобу на основі доцетакселу з підвищеною стабільністю |
Country Status (3)
| Country | Link |
|---|---|
| NO (1) | NO344525B1 (ru) |
| UA (3) | UA96273C2 (ru) |
| ZA (1) | ZA200802763B (ru) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096331A (en) * | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| WO2000006152A1 (en) * | 1998-07-30 | 2000-02-10 | Novopharm Biotech, Inc. | Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin |
| SI21222A (sl) * | 2002-05-28 | 2003-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Postopek za pripravo nanodelcev |
| KR20200083657A (ko) * | 2002-12-09 | 2020-07-08 | 아브락시스 바이오사이언스, 엘엘씨 | 약리학적 물질의 조성물 및 그 전달방법 |
| EP1701718A4 (en) * | 2003-12-23 | 2009-06-24 | Abraxis Bioscience Llc | SUBSTITUTED MELATONIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND METHOD OF ADMINISTRATION |
-
2006
- 2006-08-30 UA UAA200803886A patent/UA96273C2/ru unknown
- 2006-08-30 ZA ZA200802763A patent/ZA200802763B/xx unknown
- 2006-08-30 UA UAA200803884A patent/UA95921C2/ru unknown
- 2006-08-30 UA UAA201109120A patent/UA108840C2/ru unknown
-
2019
- 2019-03-06 NO NO20190306A patent/NO344525B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200802763B (en) | 2009-10-28 |
| NO20190306A1 (no) | 2008-05-13 |
| UA96273C2 (ru) | 2011-10-25 |
| NO344525B1 (no) | 2020-01-27 |
| UA108840C2 (uk) | 2015-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200744639A (en) | Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents | |
| ZA200705750B (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
| MY143795A (en) | Tetrahydropyridoindole derivatives | |
| WO2007087068A3 (en) | Inhibitors of tyrosine kinases and uses thereof | |
| MX2009013810A (es) | Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos. | |
| IL195256A0 (en) | Compositions of r(+)and s(-)pramipexole and methods of using the same | |
| IL217713A0 (en) | Compounds and compositions for delivering active agents | |
| WO2006013441A3 (en) | Use of probiotic bacteria for the preparation of topical compositions for skin protection | |
| WO2007025988A3 (en) | Liquid formulations of pegylated growth hormone | |
| DE602005009216D1 (de) | Zusammensetzung zur behandlung von saatgut | |
| EP1745004B8 (en) | Aryl ketone compounds and compositions for delivering active agents | |
| ZA200905126B (en) | Use of compounds of formula (i) and/or (II) for the preservation of human or animal bodies, and compositions containing the same | |
| PL1708711T3 (pl) | Kompozycje użyteczne zwłaszcza w leczeniu lub zapobieganiu zespołowi metabolicznemu | |
| WO2007064557A3 (en) | Solid biocidal compositions and methods of using the same | |
| UA95921C2 (ru) | Композиции, которые включают слаборастворимые в воде фармацевтические вещества и противомикробные вещества | |
| WO2006021401A3 (en) | Bicylononene derivatives | |
| TW200637542A (en) | Lipase inhibitor, preventing and treating agent of skin disease | |
| WO2006089218A3 (en) | Methods and compositions for modulating angiogenesis | |
| PL1874410T3 (pl) | Odbarwiająca lub rozjaśniająca kompozycja kosmetyczna zawierająca co najmniej jedną oksazolinę jako składnik aktywny | |
| FI20045076A0 (fi) | Funktionaalinen elintarvike | |
| IL172675A0 (en) | Benzofuran derivatives and their use in the treatment of microbial infections | |
| WO2007095374A3 (en) | Antimicrobial smoke flavor for oral microflora control | |
| HK1116670A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
| HK1097516A (en) | Aryl ketone compounds and compositions for delivering active agents | |
| ZA200610079B (en) | Aryl Ketone Compounds and compositions for delivering active agents |